Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithelial Cancer

Part of paid clinical trials in Philadelphia, Pennsylvania.

Sponsor
Gynecologic Oncology Group
Study ID
NCT01000259
Status
Recruiting
Apply to this trial

Conditions

  • Stage IIIA Ovarian Cancer
  • Stage IIIB Ovarian Cancer
  • Stage IIIC Ovarian Cancer
  • Stage IV Ovarian Cancer

Eligibility Criteria

Sex
FEMALE
Age
N/A - N/A
Healthy Volunteers
Not accepted

Interventions

  • Laboratory Biomarker Analysis — OTHER
    Samples are analyzed in laboratory studies

Study Details

This research study is looking at tumor tissue samples from patients who have undergone surgery for advanced stage III or stage IV ovarian epithelial cancer. Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn how tumor infiltrating T cells can predict how patients will respond to treatment.

Key Dates

Start date
Sep 30, 2004
Status verified
May 2017
Primary completion
Jan 31, 2100

Study Design

Enrollment
174 participants (estimated)

Arms

  • Arm: Ancillary-Correlative
    Previously collected tumor tissue samples are analyzed for TIL via immunohistochemistry and double immunofluorescence assays using standard immunostaining.

Primary Outcome Measure

Overall survival curves [ Time Frame: Baseline ]

Locations (1)

FacilityCityStateZIPSite coordinators
Gynecologic Oncology GroupPhiladelphiaPennsylvania19103
George Coukos
[email protected]
215-662-3316
George Coukos (PRINCIPAL_INVESTIGATOR)

Find similar trials in Philadelphia, PA

By research site
Gynecologic Oncology Group· Philadelphia, PA

Related Studies